Drug Ther Bull. 2015 Dec;53(12):141-4. doi: 10.1136/dtb.2015.12.0372.
Primary (or chronic) open-angle glaucoma (POAG or COAG) may be asymptomatic but causes progressive optic nerve damage with significant loss of visual field. Treatments aim to lower intraocular pressure (IOP) by reducing the production of aqueous humour and/or increasing its drainage. Here we update our previous articles to reflect new drugs, preservative-free preparations and fixed-dose drug combinations for POAG.
原发性（或慢性）开角型青光眼（POAG或COAG）可能没有症状，但会导致进行性视神经损伤并伴有严重的视野缺损。治疗旨在通过减少房水生成和/或增加房水引流来降低眼压。在此，我们更新之前的文章，以反映用于POAG的新药、无防腐剂制剂和固定剂量药物组合。
